Cat. Number |
A0933
|
Chemical Name |
阿维A Acitretin
|
CAS Number |
55079-83-9
|
Mol. Formula |
C21H26O3
|
Mol. Weight |
326.43
|
Qty 1 |
25mg
|
Qty 2 |
100mg
|
Appearance |
Yellow to green-yellow crystalline powder
|
Application Notes |
≥98%, multiple isomers
|
Synonym |
Neotigason, Soriatane,9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid
|
Storage condition |
-20°C
|
References |
阿维A ,Acitretin is an orally bioavailable retinoid that displays anti-inflammatory activity and is used clinically to treat psoriasis. Acitretin is a metabolite of etretinate that displays more optimized pharmacokinetic parameters. This compound activates all retinoic acid receptor subtypes (RARα/β/γ) without binding the receptor itself and also increases cAMP-PKA binding in erythrocytes. 参考文献:
Niu X, Cao W, Ma H, et al. Acitretin exerted a greater influence on T-helper (Th)1 and Th17 than on Th2 cells in treatment of psoriasis vulgaris. J Dermatol. 2012 Nov;39(11):916-21. PMID: 22913391. Saurat JH. Retinoids and psoriasis: novel issues in retinoid pharmacology and implications for psoriasis treatment. J Am Acad Dermatol. 1999 Sep;41(3 Pt 2):S2-6. PMID: 10459139. Raynaud F, Gerbaud P, Bouloc A, et al. Rapid effect of treatment of psoriatic erythrocytes with the synthetic retinoid acitretin to increase 8-azido cyclic AMP binding to the RI regulatory subunit. J Invest Dermatol. 1993 Jan;100(1):77-81. PMID: 8380830. |